Related Experiment Video
Updated: May 19, 2026

07:19
Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
Current evidence for osteoarthritis treatments
Ananthila Anandacoomarasamy1, Lyn March
1Institute of Bone and Joint Research, Royal North Shore Hospital, University of Sydney, Australia.
Therapeutic Advances in Musculoskeletal Disease
|August 8, 2012
Summary
Osteoarthritis (OA) is a common cause of disability, with no current cure. Recent advances offer new symptomatic and disease-modifying therapies for managing this prevalent condition.
Area of Science:
- Rheumatology
- Orthopedics
- Geriatrics
Background:
- Osteoarthritis (OA) is the most prevalent form of arthritis and a primary cause of chronic disability in the elderly.
- The increasing prevalence of obesity and an aging global population are exacerbating the burden of OA.
- Currently, no definitive cure for OA exists, highlighting the need for effective management strategies.
Purpose of the Study:
- To review the current evidence for symptomatic management of Osteoarthritis (OA).
- To examine nonpharmacological, pharmacological, and surgical treatment options for OA.
- To assess the existing evidence for disease-modifying therapies in OA.
Main Methods:
- Systematic review of current literature on OA management.
- Analysis of evidence for symptomatic treatments (nonpharmacological, pharmacological, surgical).
- Evaluation of evidence for disease-modifying osteoarthritis drugs (DMOADs).
Main Results:
- Nonpharmacological, pharmacological, and surgical approaches offer symptomatic relief for OA.
- Evidence for disease-modifying therapies in OA is still under development but shows promise.
- Improved understanding of OA pathophysiology is driving therapeutic innovation.
Conclusions:
- Effective symptomatic management strategies are available for Osteoarthritis (OA).
- Disease-modifying therapies for OA are an evolving area with potential for future treatment.
- Continued research is crucial for developing a cure and improving long-term outcomes for OA patients.
